Thomas E. Fehniger
Papers
2
Total Citations
29
H-Index
2
About
Thomas E. Fehniger is a translational researcher whose work bridges the critical gap between biospecimen science and clinical diagnostics, with a primary focus on chronic obstructive pulmonary disease (COPD) and cancer. His major contributions lie in advancing biobanking methodologies and biomarker discovery, particularly through the development of semi-automated, high-density sample processing systems that enable large-scale, reproducible molecular analyses. Fehniger’s most cited work (16 citations) details a 384-sample tube robot for biobank processing, a foundational tool for post-genomic studies in cancer and cardiovascular disease. His longitudinal COPD protocol (13 citations) is equally impactful, establishing a framework to identify early biomarkers of pulmonary impairment in smokers—a critical step toward early intervention in a disease that is the third leading cause of death worldwide. By demonstrating that most smokers develop some degree of lung damage, Fehniger’s research challenges conventional risk perceptions and underscores the urgency of early detection. His work exemplifies how rigorous biobanking infrastructure and targeted biomarker studies can drive precision medicine, making him a key figure in the effort to translate molecular insights into tangible clinical benefits for patients with chronic diseases.
Research Focus
Key Achievements
Top Papers
- 1
- 2